loading
전일 마감가:
$12.91
열려 있는:
$12.87
하루 거래량:
60,337
Relative Volume:
1.10
시가총액:
$1.05B
수익:
$106.66M
순이익/손실:
$15.16M
주가수익비율:
-
EPS:
-
순현금흐름:
$6.37M
1주 성능:
-11.27%
1개월 성능:
-13.22%
6개월 성능:
-6.26%
1년 성능:
+0.00%
1일 변동 폭
Value
$12.10
$12.91
1주일 범위
Value
$12.10
$13.80
52주 변동 폭
Value
$8.26
$27.10

Gyre Therapeutics Inc Stock (GYRE) Company Profile

Name
명칭
Gyre Therapeutics Inc
Name
전화
(619) 949-3681
Name
주소
12770 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO
Name
직원
391
Name
트위터
Name
다음 수익 날짜
2024-11-04
Name
최신 SEC 제출 서류
Name
GYRE's Discussions on Twitter

GYRE을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
GYRE 12.17 1.05B 106.66M 15.16M 6.37M 0.00
VRTX 451.27 115.43B 10.63B -479.80M -1.35B 13.33
REGN 754.08 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 588.30 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 250.47 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 106.54 24.89B 3.30B -501.07M 1.03B 11.54

Gyre Therapeutics Inc Stock (GYRE) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2021-04-29 재개 Stephens Overweight
2021-02-10 개시 Piper Sandler Overweight
2020-05-21 개시 Raymond James Outperform
2019-01-04 개시 Oppenheimer Outperform
2018-02-12 재확인 B. Riley FBR, Inc. Buy
2018-02-09 재확인 Chardan Capital Markets Buy
2017-12-08 개시 B. Riley FBR, Inc. Buy
2017-06-12 개시 Chardan Capital Markets Buy
2017-06-06 개시 Ladenburg Thalmann Buy
2016-06-30 개시 Rodman & Renshaw Buy
모두보기

Gyre Therapeutics Inc 주식(GYRE)의 최신 뉴스

pulisher
Nov 16, 2024

Short Interest in Gyre Therapeutics, Inc. (NASDAQ:GYRE) Declines By 16.1% - MarketBeat

Nov 16, 2024
pulisher
Nov 15, 2024

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 7.8%Here's Why - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Gyre Therapeutics Third Quarter 2024 Earnings: EPS: US$0.013 (vs US$0.68 loss in 3Q 2023) - Yahoo Finance

Nov 15, 2024
pulisher
Nov 14, 2024

Gyre Therapeutics Reports Q3 2024 Financial Results and Strategic Updates - TipRanks

Nov 14, 2024
pulisher
Nov 13, 2024

Gyre Therapeutics Reports Third Quarter 2024 and Year-To-Date Financial Results and Provides Business Update - The Manila Times

Nov 13, 2024
pulisher
Nov 13, 2024

Gyre Therapeutics Reports Third Quarter 2024 and Year-To-Date Financial Results and Provides - The Bakersfield Californian

Nov 13, 2024
pulisher
Nov 13, 2024

Gyre Therapeutics Revenue Falls 20% as Phase 3 Trial Milestone Nears Critical Data | GYRE Stock News - StockTitan

Nov 13, 2024
pulisher
Oct 23, 2024

VirTra Appoints Retired U.S. Army Lieutenant General Maria R. Gervais and Georgia POST Executive Director Mike Ayers to Board of Directors - The Manila Times

Oct 23, 2024
pulisher
Oct 22, 2024

Gyre Therapeutics Announces Last Patient Completed Pivotal Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis - The Manila Times

Oct 22, 2024
pulisher
Oct 22, 2024

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 3.8%What's Next? - MarketBeat

Oct 22, 2024
pulisher
Oct 14, 2024

AQR Capital Management LLC Invests $778,000 in Mativ Holdings, Inc. (NYSE:MATV) - Defense World

Oct 14, 2024
pulisher
Oct 08, 2024

Gyre Therapeutics (NASDAQ:GYRE) Shares Gap UpStill a Buy? - MarketBeat

Oct 08, 2024
pulisher
Oct 04, 2024

Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) market cap dropped US$51m last week; Public companies bore the brunt - Yahoo Finance

Oct 04, 2024
pulisher
Oct 03, 2024

Aligos Therapeutics (NASDAQ:ALGS) Shares Down 6.2% - Defense World

Oct 03, 2024
pulisher
Oct 03, 2024

Coronation Fund Managers Ltd. Buys 1,044 Shares of The Sherwin-Williams Company (NYSE:SHW) - Defense World

Oct 03, 2024
pulisher
Oct 03, 2024

Eaton Vance California Municipal Income Trust (NYSE:CEV) Major Shareholder Sells $282,451.70 in Stock - Defense World

Oct 03, 2024
pulisher
Oct 03, 2024

Gyre Therapeutics (NASDAQ:GYRE) Trading 3.3% HigherHere's What Happened - MarketBeat

Oct 03, 2024
pulisher
Oct 02, 2024

Gyre Therapeutics to Present at 8th Annual H.C. Wainwright MASH Investor Conference - The Manila Times

Oct 02, 2024
pulisher
Sep 18, 2024

Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Down 7.0% in August - MarketBeat

Sep 18, 2024
pulisher
Sep 18, 2024

Applied Therapeutics, PowerFleet, VF Corp, Victoria's Secret And Other Big Stocks Moving Higher On Wednesday - Benzinga

Sep 18, 2024
pulisher
Sep 17, 2024

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Up 4.9% - MarketBeat

Sep 17, 2024
pulisher
Sep 06, 2024

Gyre Therapeutics (NASDAQ:GYRE) Trading Up 6.6% - MarketBeat

Sep 06, 2024
pulisher
Sep 05, 2024

Gyre Therapeutics Inc (GYRE) Stock Price & Chart | Trade Now - Capital.com

Sep 05, 2024
pulisher
Sep 04, 2024

Gyre Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - ForexTV.com

Sep 04, 2024
pulisher
Sep 03, 2024

Gyre Therapeutics (NASDAQ:GYRE) Shares Down 8.9% - MarketBeat

Sep 03, 2024
pulisher
Sep 02, 2024

Short Interest in Gyre Therapeutics, Inc. (NASDAQ:GYRE) Grows By 5.4% - MarketBeat

Sep 02, 2024
pulisher
Aug 28, 2024

Gyre Therapeutics (NASDAQ:GYRE) Trading 4.1% Higher - MarketBeat

Aug 28, 2024
pulisher
Aug 27, 2024

Gyre Therapeutics (NASDAQ:GYRE) Shares Down 6.6% - MarketBeat

Aug 27, 2024
pulisher
Aug 26, 2024

Gyre Therapeutics (NASDAQ:GYRE) Sees Unusually-High Trading Volume - MarketBeat

Aug 26, 2024
pulisher
Aug 25, 2024

Bicara Therapeutics (NASDAQ:BCAX) Stock Quotes, Forecast and News Summary - Benzinga

Aug 25, 2024
pulisher
Aug 19, 2024

Gyre Therapeutics, Inc. (NASDAQ:GYRE) Sees Significant Growth in Short Interest - MarketBeat

Aug 19, 2024
pulisher
Aug 19, 2024

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Up 8.2% - MarketBeat

Aug 19, 2024
pulisher
Aug 19, 2024

Vanguard Group Inc. Reduces Holdings in Gyre Therapeutics, Inc. (NASDAQ:GYRE) - Defense World

Aug 19, 2024
pulisher
Aug 15, 2024

Gyre Therapeutics (NASDAQ:GYRE) Shares Gap Up to $10.40 - MarketBeat

Aug 15, 2024
pulisher
Aug 13, 2024

GYRE Stock Earnings: Gyre Therapeutics Reported Results for Q2 2024 - InvestorPlace

Aug 13, 2024
pulisher
Aug 13, 2024

Gyre Therapeutics (NASDAQ:GYRE) Trading Down 3.9% - MarketBeat

Aug 13, 2024
pulisher
Aug 13, 2024

Gyre Therapeutics Reports Second Quarter 2024 and Year-To-Date Financial Results and Provides Business Update - BioSpace

Aug 13, 2024
pulisher
Aug 13, 2024

Sidoti Events, LLC's Virtual August Micro-Cap Conference - AccessWire

Aug 13, 2024
pulisher
Aug 12, 2024

Gyre Therapeutics (NASDAQ:GYRE) Trading 6.7% Higher - MarketBeat

Aug 12, 2024
pulisher
Aug 09, 2024

Gyre Therapeutics to Present at Sidoti Virtual Investor Conference - ForexTV.com

Aug 09, 2024
pulisher
Aug 08, 2024

Gyre Therapeutics Welcomes Dr. Epstein to Leadership Team - TipRanks

Aug 08, 2024
pulisher
Aug 08, 2024

Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors - StockTitan

Aug 08, 2024
pulisher
Aug 07, 2024

Gyre Therapeutics (NASDAQ:GYRE) versus Insmed (NASDAQ:INSM) Critical Comparison - Defense World

Aug 07, 2024
pulisher
Aug 06, 2024

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Up 8.4% - MarketBeat

Aug 06, 2024
pulisher
Aug 05, 2024

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 18.9% - MarketBeat

Aug 05, 2024
pulisher
Jul 30, 2024

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 8.4% - MarketBeat

Jul 30, 2024
pulisher
Jul 29, 2024

Gyre Therapeutics (NASDAQ:GYRE) Trading Up 4.9% - MarketBeat

Jul 29, 2024
pulisher
Jul 26, 2024

Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Up 67.9% in July - MarketBeat

Jul 26, 2024
pulisher
Jul 21, 2024

Gyre Therapeutics (NASDAQ:GYRE) Shares Down 4.3% - Defense World

Jul 21, 2024
pulisher
Jul 19, 2024

Gyre Therapeutics (NASDAQ:GYRE) Trading Down 4.3% - MarketBeat

Jul 19, 2024
pulisher
Jul 18, 2024

Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Update - Defense World

Jul 18, 2024

Gyre Therapeutics Inc (GYRE) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
자본화:     |  볼륨(24시간):